betamethasone has been researched along with Pterygium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amano, S; Miyata, K; Mori, Y; Nejima, R; Ono, T; Tokunaga, T | 1 |
Beheshtnezhad, AH; Fallah, MR; Gohari, M; Hashemian, MN; Khosravi, K; Rajabi, MT | 1 |
1 trial(s) available for betamethasone and Pterygium
Article | Year |
---|---|
Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.
Topics: Administration, Topical; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Bevacizumab; Disease Progression; Drug Therapy, Combination; Female; Fibrosis; Glucocorticoids; Humans; Male; Middle Aged; Prospective Studies; Pterygium; Secondary Prevention; Treatment Outcome; Vascular Endothelial Growth Factor A | 2010 |
1 other study(ies) available for betamethasone and Pterygium
Article | Year |
---|---|
Long-term follow-up of transplantation of preserved limbal allograft and amniotic membrane for recurrent pterygium.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Allografts; Amnion; Betamethasone; Biological Dressings; Corneal Transplantation; Female; Fluorometholone; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Limbus Corneae; Male; Middle Aged; Pterygium; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Visual Acuity | 2016 |